PPI Refractory - GERD Mechanisms in Systemic Sclerosis

Not yet recruitingOBSERVATIONAL

Enrollment

147

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

July 1, 2027

Study Completion Date

July 1, 2027

Conditions

Systemic Sclerosis (SSc)GERD (Gastroesophageal Reflux Disease)

Interventions

OTHER

educational healthcare intervention

This intervention will be applyed at the beginning of the study

DIAGNOSTIC_TEST

Objective assessment of GI motility

Objetive assessment of gastrointestinal dysmotility in GI organs (esophagus, stomach, small bowel) will be performed using state of the art tests.

DIAGNOSTIC_TEST

Evaluation of GERD severity

Objective evaluation of GERD severity on PPI therapy will be performed.

All Listed Sponsors

lead

Hospital Universitari Vall d'Hebron Research Institute

OTHER

NCT07022912 - PPI Refractory - GERD Mechanisms in Systemic Sclerosis | Biotech Hunter | Biotech Hunter